Trauma
3
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
DS
KB
Kuros BiosciencesSwitzerland - Schlieren
1 program1
open fracture reductionPhase 21 trial
Active Trials
Rhythm PharmaceuticalsBOSTON, MA
1 programRegistry AutoLog Lipid Removal and Blood Component CharacterizationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Daiichi SankyoTransdermal Patch
CSL BehringFibrinogen
Kuros Biosciencesopen fracture reduction
Rhythm PharmaceuticalsRegistry AutoLog Lipid Removal and Blood Component Characterization
Clinical Trials (4)
Total enrollment: 481 patients across 4 trials
Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma
Start: Oct 2015Est. completion: Dec 2016242 patients
Phase 3Completed
Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage
Start: Feb 2015Est. completion: Apr 201740 patients
Phase 2Completed
Adjunctive Therapy to Treat Tibial Shaft Fractures
Start: Apr 2007Est. completion: May 2011
Phase 2Completed
NCT01565967Rhythm PharmaceuticalsRegistry AutoLog Lipid Removal and Blood Component Characterization
Registry AutoLog Lipid Removal and Blood Component Characterization
Start: Dec 2011Est. completion: Mar 2013199 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
6 companies competing in this space